Pharmacogenomics in lung cancer chemotherapy: a review of what the oncologist should know.

Pharmacogenomics in lung cancer chemotherapy: a review of what the oncologist should know.

Item
http://www.wikidata.org/entity/Q38256038
A Significant Statistical Advancement on the Predictive Values of ERCC1 Polymorphisms for Clinical Outcomes of Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer: An Updated Meta-AnalysisCurrent applications and future prospects of nanomaterials in tumor therapyImpact of Brachyury on epithelial-mesenchymal transitions and chemosensitivity in non-small cell lung cancer.The 5'UTR variant of ERCC5 fails to influence outcomes in ovarian and lung cancer patients undergoing treatment with platinum-based drugsSerum Metabolic Profile Alteration Reveals Response to Platinum-Based Combination Chemotherapy for Lung Cancer: Sensitive Patients Distinguished from Insensitive ones.Calotropin regulates the apoptosis of non‑small cell cancer by regulating the cytotoxic T‑lymphocyte associated antigen 4‑mediated TGF‑β/ERK signaling pathway.Association between common polymorphisms in ERCC gene and prognosis of osteosarcoma in patients treated with chemotherapy: a meta-analysis.
P2860

Pharmacogenomics in lung cancer chemotherapy: a review of what the oncologist should know.

Item
http://www.wikidata.org/entity/Q38256038
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Pharmacogenomics in lung cance ...... at the oncologist should know.
@en
type
label
Pharmacogenomics in lung cance ...... at the oncologist should know.
@en
prefLabel
Pharmacogenomics in lung cance ...... at the oncologist should know.
@en
P1433
P1476
P2093
P304
P31
P407
P433
P478
P577
P698
P921
P1433
P1476
Pharmacogenomics in lung cancer chemotherapy: a review of what the oncologist should know
@en
P2093
P304
P31
P407
P433
P478
P577
P698
P921